| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Altimmune, Inc. (ALT) has 16 insiders with recent SEC Form 4 filings, including 4 buys and 7 sells. ALT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 420.3K | $1.13M | - | |
| Other | 150.0K | $405.0K | - | |
| Other | 100.1K | $270.4K | - | |
| Other | 96.0K | $259.2K | - | |
| Dir | 48.8K | $131.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 15, 2023 | Drutz David65 | Director | Buy | 300 | $2.88 | $862.50 | +1.0% | -13.2% | +119.9% | |
| Mar 24, 2023 | Eisenstadt Richard I | Chief Financial Officer | Buy | 10,000 | $4.31 | $43,140.00 | +83.3% | -3.7% | +110.2% | |
| Mar 23, 2023 | Harris Matthew Scott | Chief Medical Officer | Buy | 10,000 | $4.22 | $42,200.00 | +42.9% | 0.0% | +116.7% | |
| Mar 23, 2023 | Drutz David65 | Director | Buy | 9,000 | $4.27 | $38,430.00 | +43.9% | 0.0% | +116.7% | |
| Dec 22, 2022 | Pisano Wayne67 | Director | Sale+OE | 20,000 | $15.01 | $300,268.00 | -70.2% | -73.2% | -40.8% | |
| Aug 31, 2022 | Garg Vipin K | President And CEO | Sell | 20,000 | $20.02 | $400,322.00 | -7.8% | -57.2% | -88.5% | |
| Aug 12, 2022 | Garg Vipin K | President And CEO | Sell | 15,000 | $15.06 | $225,889.50 | -5.5% | -39.1% | -82.7% | |
| Aug 12, 2022 | Gill John | Director | Sell | 2,714 | $15.00 | $40,710.00 | -49.5% | -39.1% | -82.7% | |
| Jul 5, 2022 | Roberts M Scot67 | Chief Scientific Officer | Sale+OE | 37,164 | $12.00 | $445,968.00 | -58.8% | +5.2% | -72.1% | |
| Jun 29, 2022 | Roberts M Scot67 | Chief Scientific Officer | Sale+OE | 5,462 | $12.00 | $65,546.18 | -23.6% | +3.9% | -70.3% |